Levodopa‐induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners

References

• Adelman J. U., Hoel R. L., Lassman M. E. The effect of L‐DOPA treatment on speech of patients with Parkinson's disease. Neurology 1970; 20: 410–411
   Web of Science ®Google Scholar
• Bunton K., Kent R. D., Kent J. F., Rosenbek J. C. Perceptuo‐acoustic assessment of prosodic impairment in dysarthria. Clinical Linguistics and Phonetics 2000; 14: 13–24
   PubMed Web of Science ®Google Scholar
• Bunton K., Kent R. D., Kent J. F., Duffy J. R. The effects of flattening fundamental frequency contours on sentence intelligibility in speakers with dysarthria. Clinical Linguistics and Phonetics 2001; 15: 181–193
   Web of Science ®Google Scholar
• Canter G. Speech characteristics in patients with Parkinson's disease: II Physiological support for speech. Journal of Speech and Hearing Disorders 1965; 30: 44–49
   PubMedGoogle Scholar
• Dagenais P. A., Brown G. R., Moore R. E. Speech rate effects upon intelligibility and acceptability of dysarthric speech. Clinical Linguistics and Phonetics 2006; 20: 141–148
   PubMed Web of Science ®Google Scholar
• Darley F. L., Aronson A. E., Brown J. R. Differential diagnostic patterns of dysarthria. Journal of Speech and Hearing Research 1969; 1: 246–269
   Google Scholar
• Darley F. L., Aronson A. E., Brown J. R. Motor Speech Disorders. WB Saunders, Philadelphia, PA 1975
   Google Scholar
• Defer G. L., Widner H., Marie R. M., Remy P., Levivier M. Core assessment programme for surgical intervention therapies in Parkinson's disease (CAPSIT‐PD). Movement Disorders 1999; 14: 572–584
   PubMed Web of Science ®Google Scholar
• De Letter M., Santens P., Van Borsel J. The effects of levodopa on word intelligibility in Parkinson's disease. Journal of Communication Disorders 2005; 38: 187–196
   PubMed Web of Science ®Google Scholar
• De Letter M., Santens P., De Bodt M., Boon P., Van Borsel J. Levodopa‐induced alterations in speech rate in advanced Parkinson's disease. Acta Neurologica Belgica 2006; 106: 19–22
   PubMed Web of Science ®Google Scholar
• Duffy J. R. Hypokinetic dysarthria. Motor Speech Disorders: substrates, differential diagnosis and management, J. R Duffy. Mosby, St. Louis, MI 1995; 166–188
   Google Scholar
• Fahn S., Elton R. L., members of the UPDRS Development Committee. Unified Parkinson Disease Rating Scale. Recent developments in Parkinson's disease, S Fahn, C. D Marsden, D. B Calne, M Goldsteing. Macmillan Healthcare Information, Florha Park, NJ 1987; 2: 153–163
   Google Scholar
• Flint A., Black S., Campbell‐Taylor I., Gailey G., Levinton C. Acoustic analysis in the differentiation between Parkinson's Disease and major depression. Journal of Psycholinguistic Research 1992; 21: 383–399
   PubMed Web of Science ®Google Scholar
• Gelb D. J., Oliver E., Gilman S. Diagnostic criteria for Parkinson Disease. Archives of Neurology 1999; 56: 33–39
   PubMed Web of Science ®Google Scholar
• German Parkinson Study Group, Neurostimulation Section. A randomized Trial of Deep‐Brain Stimulation for Parkinson's Disease. The New England Journal of Medicin 2006; 355: 896–908
   PubMed Web of Science ®Google Scholar
• Goberman A., Coelho C., Robb M. Prosodic characteristics of Parkinsonian speech: The effect of levodopa‐based medication. Journal of Medical Speech‐Language Pathology 2005; 13: 51–68
   Web of Science ®Google Scholar
• Goberman A. M., Elmer L. W. Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. Journal of Communication Disorders 2005; 38: 215–230
   PubMed Web of Science ®Google Scholar
• Ho A. K., Bradshaw J. L., Iansek R., Alfredson R. Speech volume regulation in Parkinson's disease: effects of implicit cues and explicit instructions. Neuropsychologia 1999; 37: 1453–1460
   PubMed Web of Science ®Google Scholar
• Hoehn M. M., Yahr M. D. Parkinsonism: Onset, progression and mortality. Neurology 1967; 17: 427–442
   PubMed Web of Science ®Google Scholar
• International Phonetic Association (1974). The principles of the International Phonetic Association.,. 1974, London
   Google Scholar
• Kompoliti K., Wang Q. E., Goetz C. G., Leurgans S., Raman R. Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology 2000; 25: 458–462
   Web of Science ®Google Scholar
• Lannoo E., Vingerhoets G. Flemish normative data on common neuropsychological tests: influence of age, education and gender. Psychologica Belgica 1997; 37: 141–155
   Web of Science ®Google Scholar
• Lloyd A. J. Comprehension of prosody in Parkinson's disease. Cortex 1999; 35: 389–402
   PubMed Web of Science ®Google Scholar
• Ludlow C., Connor N., Bassich C. Speech timing in Parkinson's and Huntington's Disease. Brain and Language 1987; 32: 195–214
   PubMed Web of Science ®Google Scholar
• McNamara P., Durso R. Pragmatic communication skills in patients with Parkinson's disease. Brain and Language 2003; 84: 414–423
   PubMed Web of Science ®Google Scholar
• Metter E. J. Speech disorders: Clinical Evaluation and Diagnosis. Spectrum Publications, New York 1985
   Google Scholar
• Metter E. J., Hanson W. R. Clinical and acoustical variability in hypokinetic dysarthria. Journal of Communication Disorders 1986; 19: 347–366
   PubMed Web of Science ®Google Scholar
• Molloy S. A., Rowan E. N., O'Brien J. T., McKeith I. G., Wesnes K., Burn D. J. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery and Neuropsychiatry 2006; 77: 1323–1328
   PubMed Web of Science ®Google Scholar
• Nakano K. K., Zubick H., Tyler H. R. Speech defects of parkinsonian patients : effects of levodopa therapy on speech intelligibility. Neurology 1973; 23: 865–870
   PubMed Web of Science ®Google Scholar
• Pell M. D., Cheang H. S., Leonard C. L. The impact of Parkinson's disease on vocal‐prosodic communication from the perspectives of listeners. Brain and Language 2006; 97: 123–134
   PubMed Web of Science ®Google Scholar
• Pitcairn T. K., Clemie S., Gray J. M., Pentland B. Impressions of parkinsonian patients from their recorded voices. British Journal of Disorders of Communication 1990; 25: 85–92
   PubMedGoogle Scholar
• Santens P., De Letter M., Van Borsel J., De Reuck J., Caemaert J. Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease. Brain and language 2003; 87: 253–258
   PubMed Web of Science ®Google Scholar
• Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality‐of‐life instruments: attributes and review criteria. Quality of Life Research 2002; 11: 193–205
   PubMed Web of Science ®Google Scholar
• Solomon N. P., Hixon T. J. Speech Breathing in Parkinson's Disease. Journal of Speech and Hearing Research 1993; 36: 294–310
   PubMedGoogle Scholar
• Tjaden K. A. Preliminary study of factors influencing perception of articulatory rate in Parkinson's disease. Journal of Speech, Language, and Hearing Research 2000; 43: 997–1010
   PubMed Web of Science ®Google Scholar
• Tjaden K., Wilding G. E. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings. Journal of Speech, Language and Hearing Research 2004; 47: 766–783
   PubMed Web of Science ®Google Scholar
• Vingerhoets G., Verleden S., Santens P., Miatton M., De Reuck J. Predictors of cognitive impairment in advanced Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2003; 74: 793–796
   PubMed Web of Science ®Google Scholar
• Wolfe V. I., Garvin J. S., Bacon M., Waldrop W. Speech changes in Parkinson's disease during treatment with L‐dopa. Journal of Communication Disorders 1975; 8: 271–279
   PubMed Web of Science ®Google Scholar